Feature Summary of CMTCT
-- A novel pathologic entity of melanocytic origin,
-- Variable positive immunostains for S100-protein, HMB45, and Melan-A.
-- Diffusely positive stains for SOX10, MITF, and TRIM11
-- CRTC1 & TRIM11 fusion is a signature genetic alteration.
-- Seems to be a low-grade indolent tumor with malignant potential.

=====

Disclaimer The content of "The Diagnostic Minute" is intended for educational and training purposes only. Listeners assume full responsibility for their use of the information provided in the podcast and agree to use it at their own risk. By accessing the podcast, listeners agree to hold harmless EssentialPathology, NNMI, LLC, and its affiliates, from any and all claims, damages, and expenses arising from the use or misuse of the information provided in the podcast.

http://www.essentialpathology.info/